Pfizer's acquisition can potentially accelerate the development of new drugs and treatments in the biotech industry. The acquisition can bring together Pfizer's resources and expertise with the biotech company's research and development capabilities, potentially leading to the creation of new and innovative treatments for various diseases. Read more on https://www.marketsandmarkets.com/Newsupdate/Pfizer-Expands-Cancer-Drug-Portfolio-With-$43-Billion-Biotech-Acquisition-Subscribe
read more..